drugset / Trial / NCT02430233

Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor

NCT02430233 ↗

Phase 4 Completed 129 enrolled HaEmek Medical Center, Israel
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients diagnosed with arrested pre-term labor following tocolytics at 24-34 gestational weeks will be randomly allocated to receive either vaginal micronized progesterone 400 mg/day or no treatment.

Timeline

Start
2018-12-19
Primary completion
2023-02-27
Completion
2023-02-27

Outcome

Missed primary endpoint

paper VMP given in a dosage of 200 mg twice a day following APTL is not an effective treatment to prolong pregnancy or prevent SPTD. PMID 38976270 ↗

paper there was no difference in pregnancy prolongation (mean [SD], 40.0 [17.8] vs 37.4 [20.3] days; P = .44) PMID 38976270 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg Other

Indications

No indication recorded.